APTO Aptose Biosciences Inc.

1.86
-0.04  -2%
Previous Close 1.9
Open 1.92
Price To Book 5.32
Market Cap 70262925
Shares 37,775,766
Volume 140,082
Short Ratio
Av. Daily Volume 204,192

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1b clinical hold released June 29, 2018. First patient of re-initiation announced November 26, 2018. To be completed in 2019.
APTO-253
Acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)